Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Mattia Galli, Francesco Franchi, Fabiana Rollini, Larisa H Cavallari, Davide Capodanno, Filippo Crea & Dominick J Angiolillo. (2021) Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendations. Expert Review of Clinical Pharmacology 14:8, pages 963-978.
Read now
Read now
Mattia Galli, Davide Capodanno, Felicita Andreotti, Filippo Crea & Dominick J Angiolillo. (2021) Safety and efficacy of P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary interventions. Expert Opinion on Drug Safety 20:1, pages 9-21.
Read now
Read now
Dario Calderone, Davide Capodanno & Dominick J. Angiolillo. (2020) An updated drug profile of ticagrelor with considerations on the treatment of patients with coronary artery disease and diabetes mellitus. Expert Review of Cardiovascular Therapy 18:8, pages 449-464.
Read now
Read now
Articles from other publishers (15)
Christian Weber, Andreas J R Habenicht & Philipp von Hundelshausen. (2023) Novel mechanisms and therapeutic targets in atherosclerosis: inflammation and beyond. European Heart Journal 44:29, pages 2672-2681.
Crossref
Crossref
Mattia Galli, Francesco Franchi, Fabiana Rollini & Dominick J. Angiolillo. (2023) Role of platelet function and genetic testing in patients undergoing percutaneous coronary intervention. Trends in Cardiovascular Medicine 33:3, pages 133-138.
Crossref
Crossref
Pierre Sabouret, Luigi Spadafora, David Fischman, Waqas Ullah, Michel Zeitouni, Martha Gulati, Salvatore De Rosa, Michael P. Savage, Juan Pablo Costabel, Maciej Banach, Giuseppe Biondi-Zoccai & Mattia Galli. (2023) De-escalation of antiplatelet therapy in patients with coronary artery disease: Time to change our strategy?. European Journal of Internal Medicine 110, pages 1-9.
Crossref
Crossref
Rayyan Hemetsberger, Gert Richardt, Shqipdona Lahu, Christian Valina, Maurizio Menichelli, Mohammad Abdelghani, Jochen Wöhrle, Ralph Toelg, Bernhard Witzenbichler, Nader Mankerious, Christoph Liebetrau, Isabell Bernlochner, Christian W. Hamm, Abdelhakim Allali, Michael Joner, Massimiliano Fusaro, Erion Xhepa, Alexander Hapfelmeier, Sebastian Kufner, Hendrik B. Sager, Stefanie Schüpke, Karl-Ludwig Laugwitz, Heribert Schunkert, Franz-Josef Neumann, Adnan Kastrati & Salvatore Cassese. (2022) Access Route and Clinical Outcomes After Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome Undergoing Invasive Treatment Strategy. Cardiovascular Revascularization Medicine 41, pages 122-128.
Crossref
Crossref
Dominick Angiolillo Angiolillo, Mattia Galli, Jean-Philippe Collet, Adnan Kastrati & Michelle O'Donoghue O'Donoghue. (2022) Antiplatelet therapy after percutaneous coronary intervention. EuroIntervention 17:17, pages e1371-e1396.
Crossref
Crossref
Davide Capodanno, Deepak L. Bhatt, C. Michael Gibson, Stefan James, Takeshi Kimura, Roxana Mehran, Sunil V. Rao, Philippe Gabriel Steg, Philip Urban, Marco Valgimigli, Stephan Windecker & Dominick J. Angiolillo. (2021) Bleeding avoidance strategies in percutaneous coronary intervention. Nature Reviews Cardiology 19:2, pages 117-132.
Crossref
Crossref
Dominick J. Angiolillo, Davide Cao, Usman Baber, Samantha Sartori, Zhongjie Zhang, George Dangas, Shamir Mehta, Carlo Briguori, David J. Cohen, Timothy Collier, Dariusz Dudek, Javier Escaned, C. Michael Gibson, Robert Gil, Kurt Huber, Upendra Kaul, Ran Kornowski, Mitchell W. Krucoff, Vijay Kunadian, David J. Moliterno, E. Magnus Ohman, Keith Oldroyd, Gennaro Sardella, Samin K. Sharma, Richard Shlofmitz, Giora Weisz, Bernhard Witzenbichler, Stuart Pocock & Roxana Mehran. (2021) Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI. JACC: Cardiovascular Interventions 14:13, pages 1434-1446.
Crossref
Crossref
Thanh Phuong Pham Nguyen, Colleen M. Brensinger, Warren B. Bilker, Sean Hennessy & Charles E. Leonard. (2021) Evaluation of serious bleeding signals during concomitant use of clopidogrel and hypnotic drugs. Biomedicine & Pharmacotherapy 139, pages 111559.
Crossref
Crossref
Katharina Mayer, Ralph Hein-Rothweiler, Stefanie Schüpke, Marion Janisch, Isabell Bernlochner, Gjin Ndrepepa, Dirk Sibbing, Tommaso Gori, Oliver Borst, Stefan Holdenrieder, Danny Kupka, Tobias Petzold, Christian Bradaric, Rainer Okrojek, David M. Leistner, Tobias D. Trippel, Thomas Münzel, Ulf Landmesser, Burkert Pieske, Andreas M. Zeiher, Meinrad P. Gawaz, Alexander Hapfelmeier, Karl-Ludwig Laugwitz, Heribert Schunkert, Adnan Kastrati & Steffen Massberg. (2021) Efficacy and Safety of Revacept, a Novel Lesion-Directed Competitive Antagonist to Platelet Glycoprotein VI, in Patients Undergoing Elective Percutaneous Coronary Intervention for Stable Ischemic Heart Disease. JAMA Cardiology 6:7, pages 753.
Crossref
Crossref
Dominick J. Angiolillo, Deepak L. Bhatt, Christopher P. CannonJohn W. EikelboomC. Michael GibsonShaun G. Goodman, Christopher B. Granger, David R. Holmes, Renato D. Lopes, Roxana Mehran, David J. MoliternoMatthew J. PriceJacqueline Saw, Jean-Francois TanguayDavid P. Faxon. (2021) Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention. Circulation 143:6, pages 583-596.
Crossref
Crossref
Gregorio Tersalvi, Luigi Biasco, Giacomo Maria Cioffi & Giovanni Pedrazzini. (2020) Acute Coronary Syndrome, Antiplatelet Therapy, and Bleeding: A Clinical Perspective. Journal of Clinical Medicine 9:7, pages 2064.
Crossref
Crossref
Sergio Buccheri. (2020) Measuring Thrombogenicity in ST-Elevation Myocardial Infarction ― Mechanistic Insights and Future Directions ―. Circulation Journal 84:6, pages 885-887.
Crossref
Crossref
Dominick J. Angiolillo, Usman Baber, Samantha Sartori, Carlo Briguori, George Dangas, David J. Cohen, Shamir R. Mehta, C. Michael Gibson, Rishi Chandiramani, Kurt Huber, Ran Kornowski, Giora Weisz, Vijay Kunadian, Keith G. Oldroyd, Han Ya-Ling, Upendra Kaul, Bernhard Witzenbichler, Dariusz Dudek, Gennaro Sardella, Javier Escaned, Samin Sharma, Richard A. Shlofmitz, Timothy Collier, Stuart Pocock & Roxana Mehran. (2020) Ticagrelor With or Without Aspirin in High-Risk Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention. Journal of the American College of Cardiology 75:19, pages 2403-2413.
Crossref
Crossref
Francesco Franchi, Fabiana Rollini, Gabriel Faz, Jose Ramon Rivas, Andrea Rivas, Malhar Agarwal, Maryuri Briceno, Mustafa Wali, Ahmed Nawaz, Gabriel Silva, Zubair Shaikh, Naji Maaliki, Kerolos Fahmi, Latonya Been, Andres M. Pineda, Siva Suryadevara, Daniel Soffer, Martin M. Zenni, Usman Baber, Roxana Mehran, Lisa K. Jennings, Theodore A. Bass & Dominick J. Angiolillo. (2020)
Pharmacodynamic Effects of Vorapaxar in Prior Myocardial Infarction Patients Treated With Potent Oral P2Y
12
Receptor Inhibitors With and Without Aspirin: Results of the VORA‐PRATIC Study
. Journal of the American Heart Association 9:8.
Crossref
Crossref
Sergio Buccheri & Stefan James. (2020) Individualized Duration of Dual Antiplatelet Therapy Guided by Risk Scores ― Ready for Prime Time? ―. Circulation Journal 84:2, pages 153-155.
Crossref
Crossref